Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

Aims: Most treatments for type 2 diabetes fail over time, necessitating combination therapy. We investigated the safety, tolerability and efficacy of liraglutide monotherapy compared with glimepiride monotherapy over 2 years. Methods: Participants were randomized to receive once-daily liraglutide 1....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Garber, A, Henry, R R, Ratner, R, Hale, P, Chang, C T, Bode, B
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2011
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3084519/
https://ncbi.nlm.nih.gov/pubmed/21205128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1463-1326.2010.01356.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker